Skip to content

AbbVie ABBV Change in AR

Change in AR at other companies

Pfizer logo
PfizerPFE
$65.75M+141%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$595M-35.7%
Amgen logo
AmgenAMGN
-$413M-132%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$39.8M-123%
Incyte logo
IncyteINCY
$27.03M+187%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$148M-34.5%

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$444.6B+34.7%
P/E122.3×+34.6×
P/S7.1×+1.4×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's change in AR?
AbbVie (ABBV) reported change in AR of -$87M in Q1 2026.
How has AbbVie's change in AR changed year-over-year?
AbbVie's change in AR decreased by 105.9% year-over-year, from $1.48B to -$87M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.